Myelofibrosis Clinical Trials in Westwood, Kansas

3 studies are recruiting for myelofibrosis in Westwood, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias

    This is a phase II, multicenter, open-label trial evaluating the safety and efficacy of pacritinib and selinexor in JAK inhibitor naïve patients with anemia and thrombocytopenia.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    The University of Kansas Cancer Center-Westwood, Westwood, Kansas
    Locations
    3 in total
    Run by
    John Mascarenhas

    See if you can join NCT07447817 on ClinicalTrials.gov

  2. A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

    The purpose of this clinical trial is to compare drug combinations to learn which drugs work best to prevent graft-versus-host-disease (GVHD) in people who have received a stem cell transplant. The source of stem cells is from someone who is not related and has a different blood cell type than the …

    Stage
    Phase 2
    Ages
    18 to 66
    Site
    University of Kansas Medical Center, Westwood, Kansas
    Locations
    13 in total
    Run by
    Center for International Blood and Marrow Transplant Research

    See if you can join NCT06859424 on ClinicalTrials.gov

  3. Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

    This clinical trial is evaluating whether addition of navtemadlin to ruxolitinib treatment will provide more clinical benefit than ruxolitinib alone for patients with Myelofibrosis who have a suboptimal response to ruxolitinib treatment alone. Subjects will start by receiving ruxolitinib alone in t…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Kansas Cancer Center - Westwood, Westwood, Kansas
    Locations
    215 in total
    Run by
    Kartos Therapeutics, Inc.

    See if you can join NCT06479135 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.